WELCURE
Invest Now
Welcure Drugs & Pharmaceuticals Share Price
₹8.07 0.00 (0.00%)
22 Nov, 2024 07:54
Start SIP in WELCURE
Start SIPPerformance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume0
Investment Returns
- Over 1 Month + 4.94%
- Over 3 Month + 10.1%
- Over 6 Month + 42.33%
- Over 1 Year + 99.26%
Smart Investing Starts Here Start SIP with Welcure Drugs & Pharmaceuticals for Steady Growth!
Welcure Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Welcure Drugs & Pharmaceuticals Financials
Welcure Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹8.07
0
(0%)
- Bullish Moving Average 0
- Bearish Moving Average 0
- 20 Day
- ₹7.35
- 50 Day
- ₹6.49
- 100 Day
- ₹5.78
- 200 Day
- ₹5.22
Resistance and Support
8.07
- R3 8.07
- R2 8.07
- R1 8.07
- S1 8.07
- S2 8.07
- S3 8.07
Welcure Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-14 | Quarterly Results | (Revised) |
2024-10-21 | Others | |
2024-08-14 | Quarterly Results | |
2024-06-10 | Others | Inter alia, 1. To augment of financial resources of the company, 2. To increase in authorised share capital of the company and 3. To shift branch office of the company. |
2024-05-30 | Audited Results | (Revised) |
Welcure Drugs & Pharmaceuticals F&O
About Welcure Drugs & Pharmaceuticals
- NSE Symbol
- WELCURE
- BSE Symbol
- 524661
- Managing Director & CFO
- Mr. Altaf Hussain Shah
- ISIN
- INE331C01017
Similar Stocks to Welcure Drugs & Pharmaceuticals
Welcure Drugs & Pharmaceuticals FAQs
Welcure Drugs & Pharmaceuticals share price is ₹8 As on 22 November, 2024 | 07:40
The Market Cap of Welcure Drugs & Pharmaceuticals is ₹10.9 Cr As on 22 November, 2024 | 07:40
The P/E ratio of Welcure Drugs & Pharmaceuticals is 7.5 As on 22 November, 2024 | 07:40
The PB ratio of Welcure Drugs & Pharmaceuticals is 8.1 As on 22 November, 2024 | 07:40
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.